BRPI0910993A2 - técnica de administração na linha de sutura usando toxinas botulínicas - Google Patents

técnica de administração na linha de sutura usando toxinas botulínicas

Info

Publication number
BRPI0910993A2
BRPI0910993A2 BRPI0910993A BRPI0910993A BRPI0910993A2 BR PI0910993 A2 BRPI0910993 A2 BR PI0910993A2 BR PI0910993 A BRPI0910993 A BR PI0910993A BR PI0910993 A BRPI0910993 A BR PI0910993A BR PI0910993 A2 BRPI0910993 A2 BR PI0910993A2
Authority
BR
Brazil
Prior art keywords
suture line
botulinum toxins
administration technique
line administration
headache
Prior art date
Application number
BRPI0910993A
Other languages
English (en)
Inventor
Andrew M Blumenfeld
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0910993A2 publication Critical patent/BRPI0910993A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0910993A 2008-04-03 2009-03-31 técnica de administração na linha de sutura usando toxinas botulínicas BRPI0910993A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/062,372 US8617571B2 (en) 2008-04-03 2008-04-03 Suture line administration technique using botulinum toxin
PCT/US2009/038950 WO2009124046A1 (en) 2008-04-03 2009-03-31 Suture line administration technique using botulinum toxins

Publications (1)

Publication Number Publication Date
BRPI0910993A2 true BRPI0910993A2 (pt) 2015-12-29

Family

ID=41016982

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910993A BRPI0910993A2 (pt) 2008-04-03 2009-03-31 técnica de administração na linha de sutura usando toxinas botulínicas

Country Status (12)

Country Link
US (7) US8617571B2 (pt)
EP (2) EP2392344B1 (pt)
CN (1) CN102056620A (pt)
AT (1) ATE531387T1 (pt)
AU (1) AU2009231786B2 (pt)
BR (1) BRPI0910993A2 (pt)
CA (1) CA2720112C (pt)
DK (1) DK2282766T3 (pt)
ES (2) ES2372678T3 (pt)
MX (1) MX2010010885A (pt)
NZ (3) NZ600858A (pt)
WO (1) WO2009124046A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US6440312B1 (en) 2000-05-02 2002-08-27 Kai Technologies, Inc. Extracting oil and water from drill cuttings using RF energy
US20100266638A1 (en) 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
US9078892B2 (en) * 2004-02-26 2015-07-14 Allergan, Inc. Methods for treating pain and for treating a medication overuse disorder
US20050191321A1 (en) * 2004-02-26 2005-09-01 Allergan, Inc. Methods for treating headache
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US7749515B2 (en) 2005-02-01 2010-07-06 Allergan, Inc. Targeted delivery of botulinum toxin to the sphenopalatine ganglion
US7655244B2 (en) 2005-02-01 2010-02-02 Allergan, Inc. Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
US8617571B2 (en) * 2008-04-03 2013-12-31 Allergan, Inc. Suture line administration technique using botulinum toxin
US20120251576A1 (en) * 2009-12-15 2012-10-04 Ira Sanders Treatment of Nasal and Sinus Disorders
WO2012174123A1 (en) 2011-06-13 2012-12-20 Allergan, Inc. Treatment of psychological trauma
US9480731B2 (en) 2013-12-12 2016-11-01 Medy-Tox, Inc. Long lasting effect of new botulinum toxin formulations
CN105251041A (zh) * 2015-10-28 2016-01-20 钊桂英 一种纯天然胶原蛋白医用缝合线及制备方法
WO2018053004A2 (en) 2016-09-13 2018-03-22 Allergan, Inc. Non-protein clostridial toxin compositions
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
WO2019075396A1 (en) * 2017-10-12 2019-04-18 Leslie Tufts METHOD AND APPARATUS FOR INJECTING NEUROTOXIN IN A LOCALIZED AREA
EP3817766A2 (en) 2018-07-05 2021-05-12 Allergan Pharmaceuticals International Limited Combination therapy with cgrp antagonists and clostridial derivatives
US20210128724A1 (en) 2019-07-05 2021-05-06 Allergan Pharmaceuticals International Limited Cgrp antagonists and clostridial derivatives for the treatment of cortical spreading depression associated disorders
WO2021005494A1 (en) 2019-07-05 2021-01-14 Allergan Pharmaceuticals International Limited Cgrp antagonists and clostridial derivatives for the treatment of neuropsychiatric and neurological disorders
WO2021005493A1 (en) 2019-07-05 2021-01-14 Allergan Pharmaceuticals International Limited Cgrp antagonists and botulinum toxins for the treatment of inflammatory and neurologic disorders
CA3181130A1 (en) 2020-06-03 2021-12-09 William J. Binder Zonal and targeted methods and uses for treating a migraine disorder
WO2023091469A1 (en) * 2021-11-17 2023-05-25 The Board Of Trustees Of The Leland Stanford Junior University Targeting periosteal tissue for delivery of therapeutics
WO2024112924A2 (en) * 2022-11-22 2024-05-30 AEON Biopharma, Inc. Optimization of botulinum toxin treatment of migraine and other headache disorders

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA962933A (en) 1969-12-05 1975-02-18 Yutaka Hori Metal foil-plastic laminated film and method of producing the same
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
PT1086702E (pt) * 1994-05-09 2005-08-31 William J Binder Neurotoxinas pre-sinapticas para tratamento da dor de cabeca devida a enxaqueca
US5670484A (en) 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
EP1128844B1 (en) 1998-10-27 2006-01-04 Mayo Foundation For Medical Education And Research Botulinum toxins for enhancing wound healing
US6358917B1 (en) * 1999-08-24 2002-03-19 Jean D. A. Carruthers Cosmetic use of botulinum toxin for treatment of downturned mouth
US6265379B1 (en) 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US6787517B1 (en) * 2000-12-29 2004-09-07 Allergan, Inc. Agent and methods for treating pain
CN1258381C (zh) 2001-07-27 2006-06-07 路易斯安那州州立大学及农业机械学院管理委员会 用在痤疮治疗或预防中的肉毒杆菌毒素
US6623742B2 (en) 2001-09-17 2003-09-23 Allergan, Inc. Methods for treating fibromyalgia
DE10150415A1 (de) 2001-10-11 2003-05-15 Andres O Ceballos-Baumann Arzneimittel zur Prophylaxe und Therapie von Depressionen
KR20040094756A (ko) 2002-03-01 2004-11-10 엘란 파마슈티칼스, 인크. 신경 포착 증후군의 치료 방법
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US7393537B2 (en) 2003-04-25 2008-07-01 Allergan, Inc. Botulinum toxin for treatment of obsessive compulsive finger biting disorder
US6838434B2 (en) 2003-05-02 2005-01-04 Allergan, Inc. Methods for treating sinus headache
US8734810B2 (en) * 2003-10-29 2014-05-27 Allergan, Inc. Botulinum toxin treatments of neurological and neuropsychiatric disorders
US8617572B2 (en) * 2003-10-29 2013-12-31 Allergan, Inc. Botulinum toxin treatments of depression
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
US20050191321A1 (en) 2004-02-26 2005-09-01 Allergan, Inc. Methods for treating headache
US9078892B2 (en) 2004-02-26 2015-07-14 Allergan, Inc. Methods for treating pain and for treating a medication overuse disorder
US7691381B2 (en) * 2004-04-15 2010-04-06 Allergan, Inc. Stabilized biodegradable neurotoxin implants
US7655244B2 (en) 2005-02-01 2010-02-02 Allergan, Inc. Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
WO2006082339A1 (fr) 2005-02-02 2006-08-10 France Telecom Procede et systeme d'identification par code contextuel
US7910116B2 (en) 2005-08-24 2011-03-22 Allergan, Inc. Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
US8617571B2 (en) * 2008-04-03 2013-12-31 Allergan, Inc. Suture line administration technique using botulinum toxin
US9066851B2 (en) * 2008-12-04 2015-06-30 Botulinum Toxin Research Associates, Inc. Extended length botulinum toxin formulation for human or mammalian use
WO2012051447A1 (en) * 2010-10-14 2012-04-19 Allergan, Inc. Targeted delivery of targeted exocytosis modulators to the sphenopalatine ganglion for treatment of headache disorders
WO2012174123A1 (en) * 2011-06-13 2012-12-20 Allergan, Inc. Treatment of psychological trauma
AU2013232758C1 (en) * 2012-03-12 2015-03-05 William J. Binder Treatment of migraine headaches with presynaptic neurotoxin
US8420106B1 (en) * 2012-03-12 2013-04-16 William J. Binder Extramuscular treatment of traumatic-induced migraine headache
US9068851B2 (en) 2013-01-24 2015-06-30 Sap Se Location and distance based reminders
WO2016149092A1 (en) * 2015-03-13 2016-09-22 Allergan, Inc. Improved injection paradigm for administration of botulinum toxins
EP3817766A2 (en) * 2018-07-05 2021-05-12 Allergan Pharmaceuticals International Limited Combination therapy with cgrp antagonists and clostridial derivatives

Also Published As

Publication number Publication date
US20090252764A1 (en) 2009-10-08
ES2398904T3 (es) 2013-03-22
AU2009231786A1 (en) 2009-10-08
NZ588648A (en) 2012-11-30
WO2009124046A1 (en) 2009-10-08
MX2010010885A (es) 2010-11-04
NZ600858A (en) 2012-12-21
US20230263869A1 (en) 2023-08-24
EP2282766A1 (en) 2011-02-16
US20180078622A1 (en) 2018-03-22
EP2282766B1 (en) 2011-11-02
DK2282766T3 (da) 2012-01-02
US8617571B2 (en) 2013-12-31
US10874722B2 (en) 2020-12-29
US9827297B2 (en) 2017-11-28
US10220079B2 (en) 2019-03-05
CN102056620A (zh) 2011-05-11
CA2720112C (en) 2014-09-23
AU2009231786B2 (en) 2015-06-18
US20190240299A1 (en) 2019-08-08
US20140079687A1 (en) 2014-03-20
EP2392344B1 (en) 2012-12-19
US20160151468A1 (en) 2016-06-02
ATE531387T1 (de) 2011-11-15
US9248168B2 (en) 2016-02-02
ES2372678T3 (es) 2012-01-25
CA2720112A1 (en) 2009-10-08
US20210121543A1 (en) 2021-04-29
NZ603717A (en) 2014-02-28
EP2392344A1 (en) 2011-12-07

Similar Documents

Publication Publication Date Title
BRPI0910993A2 (pt) técnica de administração na linha de sutura usando toxinas botulínicas
BRPI0417493A (pt) terapia com toxina botulìnica para distúrbios da pele
TW200503751A (en) Methods for treating sinus headache
BR0309888A (pt) Tratamento intracraniano de distúrbios neuropsiquiátricos por neurotoxinas clostridiais tal como a toxina da botulina
MX2010006731A (es) Uso de un componente neurotoxico de un complejo de toxina de clostridium botulinum para reducir o prevenir efectos secundarios.
BR0111698A (pt) Método para o tratamento de um distúrbio de movimento
WO2005037203A3 (en) Methods and reagents for the treatment of immunoinflammatory disorders
ATE411813T1 (de) Behandlungen mit botulinum toxin von neurologische und neuropsychiatrische krankheiten
SG146653A1 (en) Methods and reagents for the treatment of immunoinflammatory disorders
PT2037956E (pt) Utilização terapêutica simultânea, separada ou sequencial no tempo de, pelo menos, uma neurotoxina botulínica e de, pelo menos, um opiáceo
DE602007002625D1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
CY1110620T1 (el) Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας
BR0307496A (pt) Uso de uma neurotoxina clostridiana, bem como composição farmacêutica utilizável no tratamento de um distúrbio da glândula mamária
WO2009009393A3 (en) Chromium complexes for improvement of memory and cognitive function
WO2009130600A8 (en) Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
DE602005020309D1 (de) Dehnungsstreifenbehandlung mit botulinumtoxin
DE602006006068D1 (de) Verwendung von botulintoxin zur verbesserung der magenentleerung und/oder behandlung von gerd
WO2007100590A3 (en) Methods for treating cellulite
WO2007087154A3 (en) Methods for enhancing therapeutic effects of a neurotoxin
WO2010048264A3 (en) Methods and compositions for the treatment of immunoinflammatory disorders
BRPI0514836A (pt) uso de toxina botulìnica para tratamento de uma deformidade da nádega
WO2008016665A3 (en) Imidazoacridine compounds for treating flt3 -mediated disorders
BRPI0509478A (pt) tratamento de ferida por pressão
BRPI0514895A (pt) tratamento de estria
WO2006078588A3 (en) Improved methods for treating headache

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.